| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 11356 | 2021 |
| Distinct roles in vivo for the ubiquitin–proteasome system and the autophagy–lysosomal pathway in the degradation of α-synuclein D Ebrahimi-Fakhari, I Cantuti-Castelvetri, Z Fan, E Rockenstein, ... Journal of Neuroscience 31 (41), 14508-14520, 2011 | 450 | 2011 |
| The circadian protein BMAL1 regulates translation in response to S6K1-mediated phosphorylation JO Lipton, ED Yuan, LM Boyle, D Ebrahimi-Fakhari, E Kwiatkowski, ... Cell 161 (5), 1138-1151, 2015 | 356 | 2015 |
| N omenclature of genetic movement disorders: R ecommendations of the international P arkinson and movement disorder society task force C Marras, A Lang, BP van de Warrenburg, CM Sue, SJ Tabrizi, L Bertram, ... Movement Disorders 31 (4), 436-457, 2016 | 340 | 2016 |
| Protein degradation pathways in Parkinson’s disease: curse or blessing D Ebrahimi-Fakhari, L Wahlster, PJ McLean Acta neuropathologica 124, 153-172, 2012 | 312 | 2012 |
| The evolving spectrum of PRRT2-associated paroxysmal diseases D Ebrahimi-Fakhari, A Saffari, A Westenberger, C Klein Brain 138 (12), 3476-3495, 2015 | 309 | 2015 |
| Abnormal mTOR activation in autism KD Winden, D Ebrahimi-Fakhari, M Sahin Annual review of neuroscience 41 (1), 1-23, 2018 | 209 | 2018 |
| Autism and the synapse: emerging mechanisms and mechanism-based therapies D Ebrahimi-Fakhari, M Sahin Current opinion in neurology 28 (2), 91-102, 2015 | 196 | 2015 |
| Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism D Ebrahimi-Fakhari, A Saffari, L Wahlster, J Lu, S Byrne, GF Hoffmann, ... Brain 139 (2), 317-337, 2016 | 167 | 2016 |
| Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway J Klucken, AM Poehler, D Ebrahimi-Fakhari, J Schneider, S Nuber, ... Autophagy 8 (5), 754-766, 2012 | 167 | 2012 |
| Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex D Ebrahimi-Fakhari, A Saffari, L Wahlster, A Di Nardo, D Turner, TL Lewis, ... Cell reports 17 (4), 1053-1070, 2016 | 161 | 2016 |
| Tuberous sclerosis complex FJ DiMario, M Sahin, D Ebrahimi-Fakhari Pediatric Clinics 62 (3), 633-648, 2015 | 156 | 2015 |
| Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study D Ebrahimi-Fakhari, LL Mann, M Poryo, N Graf, R von Kries, B Heinrich, ... Orphanet Journal of Rare Diseases 13, 1-8, 2018 | 139 | 2018 |
| Ante-, peri-and postnatal factors associated with intraventricular hemorrhage in very premature infants M Poryo, JC Boeckh, L Gortner, M Zemlin, P Duppré, D Ebrahimi-Fakhari, ... Early human development 116, 1-8, 2018 | 127 | 2018 |
| EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy S Byrne, L Jansen, JM U-King-Im, A Siddiqui, HGW Lidov, I Bodi, L Smith, ... Brain 139 (3), 765-781, 2016 | 119 | 2016 |
| Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies D Ebrahimi-Fakhari, LJ Saidi, L Wahlster Acta neuropathologica communications 1, 1-15, 2013 | 112 | 2013 |
| Molecular chaperones in Parkinson's disease–present and future D Ebrahimi-Fakhari, L Wahlster, PJ McLean Journal of Parkinson's disease 1 (4), 299-320, 2011 | 111 | 2011 |
| Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells D Ebrahimi-Fakhari, L Wahlster, F Bartz, J Werenbeck-Ueding, ... Human molecular genetics 25 (16), 3588-3599, 2016 | 106 | 2016 |
| Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force–an update LM Lange, P Gonzalez‐Latapi, R Rajalingam, MAJ Tijssen, ... Movement Disorders 37 (5), 905-935, 2022 | 92 | 2022 |
| Movement disorders in treatable inborn errors of metabolism D Ebrahimi‐Fakhari, C Van Karnebeek, A Münchau Movement disorders 34 (5), 598-613, 2019 | 71 | 2019 |
Pamela McLeanMayo ClinicVerificeret mail på mayo.edu